Enovis (ENOV) Stock Price

Enovis Corp. generates revenue through its two business segments, Prevention & Recovery and Reconstructive. The Prevention & Recovery segment sells rigid bracing products, orthopedic soft goods, vascular systems, compression garments, and hot and cold therapy products to clinical rehabilitation and sports medicine markets, including recovery sciences products like bone growth stimulators and electrical stimulators for pain management. The Reconstructive segment focuses on knee, hip, shoulder, elbow, foot, ankle, and finger implant products, surgical productivity solutions, and Novastep, a minimally invasive surgery (MIS) foot and ankle solution, targeting healthcare providers and surgical centers. Medical device manufacturers and healthcare institutions are the primary buyers of these products, with the company's solutions addressing both preventive care and reconstructive procedures. The company's product portfolio includes clinically differentiated medical devices designed for specific applications in reconstructive surgery, rehabilitation, pain management, and physical therapy. By manufacturing and distributing these products under its own brand, Enovis Corp. serves healthcare providers seeking innovative solutions for patient recovery and surgical efficiency. The Prevention & Recovery segment's offerings, such as compression garments and therapy products, cater to both clinical and sports medicine applications, while the Reconstructive segment's implants and surgical tools are used in orthopedic procedures worldwide. The company's focus on minimally invasive solutions like Novastep enhances its appeal to surgeons and hospitals looking to reduce patient recovery times. Enovis Corp. targets healthcare providers, surgical centers, and rehabilitation facilities as key customers for its medical devices. The Prevention & Recovery segment's products, including bone growth stimulators and electrical stimulators, are sold to clinical rehabilitation and sports medicine markets, while the Reconstructive segment's knee, hip, and foot implant products are distributed to orthopedic surgical centers. The company's revenue streams are derived from direct sales of these branded medical devices, with no mention of third-party partnerships or external distribution channels in the business description.